After years of fending off rival #Humira #biosimilars AbbVie has agreed to relinquish market exclusivity in 2023.… https://t.co/26IT4lCLCO
After years of fending off rival #Humira #biosimilars AbbVie has agreed to relinquish market exclusivity in 2023.… https://t.co/26IT4lCLCO